Abstract
Exploration of the genetic basis of Visceral Leishmaniasis (VL) has identified substantial amounts of biomarkers and thus has contributed to improve understanding of the pathogenesis of the VL. However, such findings have not been converted into disease control strategies. The identification of immunotherapeutic targets depends on the identification of metabolic pathways of the host, cons…